WILLIAM H. ORRICK, United States District Judge.
Currently before me is defendant John Sorensen's second motion to dismiss claims asserted by plaintiff relator John Orten under the federal False Claims Act (FCA). Pursuant to Civil Local Rule 7-1(b), this matter is appropriate for resolution without oral argument, and I hereby VACATE the March 30, 2016 hearing. Among several issues asserted in the motion, the public disclosure bar precludes Orten's claim regarding "upcoding" and Orten's failure to identify a Medicare statute or regulation that Sorensen violated that is a condition of payment makes meritless the "Star Ratings" claim. I grant in part and deny in part the motion to dismiss.
In my November 2015 Order, I dismissed Orten's FCA cause of action based on "Star Rating" allegations with leave to amend because Orten failed to allege sufficient facts and to identify particular statutory or regulatory requirements that are conditions of payment. Dkt. No. 74 at 8.
Orten filed his Third Amended Complaint on December 9, 2015. Sorensen again moves to dismiss the FCA claims based on Star Ratings and upcoding allegations, as well as the conspiracy and state law claims. Dkt. No. 84. The United States (the real party in interest) has filed a second "Statement of Interest," explaining
Under Federal Rule of Civil Procedure 12(b)(6), a district court must dismiss a complaint if it fails to state a claim upon which relief can be granted. To survive a Rule 12(b)(6) motion to dismiss, the plaintiff must allege "enough facts to state a claim to relief that is plausible on its face." Bell Atl. Corp. v. Twombly, 550 U.S. 544, 556, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007). A claim is facially plausible when the plaintiff pleads facts that "allow the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (citation omitted). There must be "more than a sheer possibility that a defendant has acted unlawfully." Id. While courts do not require "heightened fact pleading of specifics," a plaintiff must allege facts sufficient to "raise a right to relief above the speculative level." Twombly, 550 U.S. at 555, 570, 127 S.Ct. 1955.
"Because they involve allegations of fraud, qui tam actions under the FCA must meet not only the requirement of Rule 8, but also the particularity requirements of Rule 9." United States ex rel. Lee v. Corinthian Colls., 655 F.3d 984, 992 (9th Cir.2011). Under Federal Rule of Civil Procedure 9(b), a party must "state with particularity the circumstances constituting fraud or mistake," including "the who, what, when, where, and how of the misconduct charged." Vess v. Ciba-Geigy Corp. USA, 317 F.3d 1097, 1106 (9th Cir.2003) (internal quotation marks omitted). However, "Rule 9(b) requires only that the circumstances of fraud be stated with particularity; other facts may be pleaded generally, or in accordance with Rule 8." United States ex rel. Lee v. Corinthian Colls., 655 F.3d at 992.
In deciding whether the plaintiff has stated a claim upon which relief can be granted, the Court accepts the plaintiff's allegations as true and draws all reasonable inferences in favor of the plaintiff. Usher v. City of Los Angeles, 828 F.2d 556, 561 (9th Cir.1987). However, the court is not required to accept as true "allegations that are merely conclusory, unwarranted deductions of fact, or unreasonable inferences." In re Gilead Scis. Sec. Litig., 536 F.3d 1049, 1055 (9th Cir.2008).
In the TAC, Orten makes explicit that his FCA claim is based in part on allegations that Sorensen engaged in "upcoding" to defraud the Medicare program. Specifically he adds new allegations that NAHC pushed employees to increase "Resource Utilization Group" (RUG) rates to maximize the reimbursements NAHC received from the government. TAC ¶ 28. A NAHC VP informed Orten (and other administrators) that NAHC had a company policy of "pushing the limit of maximizing Medicare reimbursement" by upcoding and using questionable and unnecessary therapies. Id. As part of that effort, NAHC pushed the use of "Accelerated Care Plus" (ACP) equipment, where there was no benefit to patients but a "windfall" in therapy minutes that NAHC could charge the government. Id. ¶ 29. These unnecessary and inappropriate therapies also included use of the "ACP bike." Id. ¶ 30. Orten alleges that he was also aware of the pervasive practice of RUG upcoding for "Activities of Daily Living" (ADLs), because the same
Orten alleges that NAHC continued to perform unnecessary therapy on residents, and thereby engaged in RUG upcoding, after the March 10, 2010 Washington Post article that identified NAHC as a target of a government investigation into upcoding. Id. He asserts that Sorensen was personally involved in the upcoding both before and after the Washington Post article, and actively encouraged the fraud by instructing staff to perform unnecessary treatments that would allow maximum billing with minimal cost to NAHC. Id. ¶ 32. He states that Sorensen worked with unnamed individuals outside of NAHC, including unnamed doctors and administrators, to accomplish his goals. Id.
Under the current version of the FCA, the public disclosure bar precludes a claim:
31 U.S.C. § 3730(e)(4) (emphasis added). The FCA was amended by the Patient Protection and Affordable Care Act in March 2010. Conduct occurring before March 2010 is governed by the 1986 version of the FCA public disclosure bar which provided that:
31 U.S.C. § 3730(e)(4)(1986) (emphasis added); see also U.S. ex rel. Carter v. Bridgepoint Educ., Inc., No. 10-CV-1401 JLS WVG, 2015 WL 4892259, at *2 (S.D.Cal. Aug. 17, 2015) ("When the conduct at issue spans both pre and post-amendment, courts have held that conduct which occurred pre-amendment is subject to the prior version of the statute.").
Sorensen and the government contend that Orten's upcoding allegations are barred by the public disclosure for multiple reasons: (i) the substance of the RUG
In the March 29, 2010 Washington Post article, it was disclosed that a division of the Health & Human Services Department (HHS) was specifically investigating NAHC for upcoding:
See Declaration of Jonathan Madore (Dkt. No. 70-1), Ex. 1; see also id., Ex. 2 (SEIU April 6, 2010 press release alleging excessive physical and occupational therapy services at NAHC based on data analyses).
The Supreme Court has repeatedly observed that the text of the public disclosure bar applies with a "broad sweep" to the forum in which the disclosure occurs, and that the phrase "allegations or transactions" is "wide-reaching." Schindler Elevator Corp. v. U.S. ex rel. Kirk, 563 U.S. 401, 408, 131 S.Ct. 1885, 179 L.Ed.2d 825 (2011). Importantly, the public disclosure "need not contain an explicit `allegation' of fraud, so long as the material elements of the allegedly fraudulent `transaction' are disclosed in the public domain." U.S. ex rel. Found. Aiding The Elderly v. Horizon W., 265 F.3d 1011, 1014 (9th Cir.) opinion amended on denial of reh'g sub nom. U.S. ex rel. Found. Aiding Elderly v. Horizon W., Inc., 275 F.3d 1189 (9th Cir. 2001). Put another way, if the public disclosure "was sufficient to enable [the government] adequately to investigate the case and to make a decision whether to prosecute," the bar will apply to subsequent FCA suits based on similar allegations. Id. at 1016 (internal quotations omitted); see also United States v. Kiewit Pac. Co., 41 F.Supp.3d 796, 803 (N.D.Cal.2014) (bar applies when prior disclosure sufficient to place government "on notice" of alleged fraud).
I conclude that the Washington Post article and the SEIU press release publicly disclosed the exact type of fraudulent conduct, upcoding by providing unneeded therapy services, on which Orten rests his current upcoding FCA allegations. In these circumstances, the government did not need the "details" Orten allegedly provided — specific identification of a few types of unnecessary therapy and services being provided to NAHC clients — in order to recognize or investigate fraud by NAHC.
The two cases Orten relies on to argue that the Washington Post article does not disclose the basis for his claims because that article did not disclose actual instances of fraud but only suspicion of fraud
Orten contends he was the original source of the upcoding allegations at issue because he voluntarily disclosed them to the government in his July 2014 interview prior to filing his SAC in April 2015. See, e.g., Dkt. No. 71 (Relator's Response to Government's Statement of Interest) at 6. In his TAC, he does not specifically identify when he disclosed the "upcoding for unnecessary therapy" allegations to the government, but asserts that he submitted a report regarding "fraud" occurring at the NAHC Ramona facility to the Office of Inspector General on November 23, 2012. TAC ¶ 66. He also discussed his allegations of "fraud" during an April 2013 meeting with representatives of the OIG. Id. ¶ 72. In his Opposition to this motion, Orten again argues that he disclosed his upcoding allegations in his second meeting with government investigators in July 2014. Oppo. at 11.
With respect to conduct occurring before the March 2010 FCA amendments, Orten's claims are barred because there is no evidence Orten disclosed material information to the government before he filed his FCA suit. As explained in the initial and second declarations of Jonathan Madore, there was nothing in Orten's November 2012 report to the OIG (or in any follow up emails) which disclosed that Orten had any personal knowledge about upcoding at NAHC. Declaration of Jonathan Madore (Dkt. No. 70) ¶ 4; Second Declaration of Jonathan Madore (Dkt. No. 87-1) ¶¶ 4-9. Nor was there any material information provided by Orten in the subsequent government interview in July 2014, that "added" to the government's longstanding investigation of NAHC's upcoding practices for unnecessary therapy. Madore Decl. ¶ 5.
Orten responds that he has met the materiality requirement — despite the testimony of Madore — by showing the government that fraud that was previously disclosed continued after the disclosure (here, that the fraud continued after the March 29, 2010 Washington Post article). Oppo. at 10-11. Orten misstates the law. Where the allegations are simply that the same fraud previously disclosed is ongoing, those allegations will be barred. The cases Orten relies on are not to the contrary and deal with situations where changed circumstances make the relator's new disclosures of ongoing fraud material to the government. See, e.g., U.S. ex rel. Booker v. Pfizer, Inc., 9 F.Supp.3d 34, 46 (D.Mass.2014) (allegations that a qui tam defendant in a prior suit, who agreed in its settlement with the government not repeat its fraud, repeated its prior fraud were not barred); U.S. ex rel. Hoggett v. Univ. of Phoenix, No. 2:10-CV-02478-MCE, 2012 WL 2681817, at *4 (E.D.Cal. July 6, 2012) ("If, as Relators allege, the new procedures cover up a continuation of the previous fraud, then Relators have provided information that is independent of and materially adds to the information publicly disclosed" during a prior FCA case); but see U.S. ex rel. Bogina v. Medline Indus., Inc., 809 F.3d 365, 370 (7th Cir.2016) (allegations "on information and belief" that after settling with the government, a defendant was still conducting the same fraud are insufficient to state a claim under Rule 9(b)). There are no similar changed circumstances identified here.
Orten's FCA allegations based on alleged upcoding for unnecessary therapy by NAHC fall under the public disclosure bar and are DISMISSED with prejudice as to Orten.
In my prior Order, I dismissed Orten's FCA claims based on the Star Ratings allegations because Orten had failed to "identify particular statutory or regulatory requirements that are true conditions of payment and not simply conditions of participation," in the Medicare program. Dkt. No. 74 at 8. I explained that in the Ninth Circuit, allegations of fraud based on failure to comply with regulations could constitute an actionable FCA claim in the Medicare context only where "compliance with a regulation is a condition of payment as opposed to a condition of program
In his TAC and Opposition to Sorensen's current motion to dismiss, Orten relies heavily on the fact that the "surveys" (which are the basis for the Star Ratings allegedly inflated by the fraudulent conduct of Sorensen and NAHC) form the basis of the ratings assigned to healthcare entities on the Medicare program's "Nursing Home Compare" website. Oppo. at 17. However, that arguable fraud on the Medicare program and the public (who might rely on those ratings in selecting care facilities) is not cognizable under the FCA absent the identification of a regulation where compliance is a condition to payment under that program. The fact that regulations require health care entities to participate in the surveys, and that the results of those surveys are published to the public, does not make fraud related to those surveys actionable under the FCA.
Orten's FCA claim related to Star Ratings (and the Nursing Home Compare website) is DISMISSED with prejudice.
In my prior Order, I dismissed Orten's FCA claims asserted under California law "so that Orten can plead facts showing how false claims were submitted to the states in violation of the California" statute. November 2015 Order at 12. In the TAC, Orten adds the following:
TAC ¶ 80. In his Opposition, Orten asserts that as a NAHC administrator he had personal knowledge that there were residents who qualified for both Medicare and Medicaid, and that some residents would "under standard procedures, simultaneously have their coverage paid for by both Medicare and Medicaid in the manner described in the TAC." Oppo. at 18-19.
Sorensen argues that this addition is still insufficient because the "dual coverage" allegation is insufficient to show the submission of a false claim to California and Orten fails (as he failed with respect to the federal claims) to adequately plead facts showing that Sorensen had the requisite scienter to defraud California.
Sorensen points out that there are no facts alleged in the TAC regarding fraud committed under the Washington State FCA, other than the broad allegations at paragraph 93 that "[u]pon information and belief, Defendants' actions described herein occurred in the State of Washington as well. Because state Medicaid programs operate in conjunction with Medicare, Defendants defrauded California when they defrauded the United States." TAC ¶ 93.
Given Orten's failure to allege any facts about any conduct occurring in Washington State — despite being given the opportunity to do so in my prior Order — this claim is DISMISSED with prejudice.
In the prior Order, Orten's conspiracy claim was dismissed because Orten failed to "allege any facts expressly connecting Sorensen to non-NAHC employees as part of the alleged conspiracy to submit fraudulent Medicare claims." November 2015 Order at 12. In his TAC, the only new allegation regarding the conspiracy claim is that NAHC facilities:
TAC ¶ 60; Oppo. at 21. The remaining substantive federal and California FCA claims are those based on the referral and regeneration scheme. As to that scheme, in his TAC Orten alleges that in October 2011, Sorensen directed staff to focus on Medicare "Part B." TAC ¶ 43. The resulting corporate push was by the NACH VP (who instructed staff to engage in the upcoding for ACP therapy and ADL billing identified by Orten in his TAC), and led to patients being reclassified for additional but unnecessary services covered by Medicare Part B. Id. In Opposition, Orten also relies on Paragraph 60 of the TAC where he alleges that NAHC:
At this stage, that allegation is sufficient for purposes of the FCA conspiracy claim based on the alleged referral and regeneration scheme.
The motion to dismiss the conspiracy claim is DENIED.
Orten's FCA claims based on allegations regarding Star Ratings and upcoding are DISMISSED with prejudice. Orten's claim under Washington State law is DISMISSED with prejudice. The motion to dismiss is otherwise DENIED, and Orten may proceed with his federal and California FCA and conspiracy claims based on the referral and regeneration allegations.
Sorensen shall file his answer within fourteen (14) days of the date of this Order. A Case Management Conference will be held on